Compounds > l 368899
Page last updated: 2024-09-03

l 368899 and 15-keto-13,14-dihydroprostaglandin f2alpha

l 368899 has been researched along with 15-keto-13,14-dihydroprostaglandin f2alpha in 1 studies

Compound Research Comparison

Studies
(l 368899)		Trials
(l 368899)		Recent Studies (post-2010)
(l 368899)		Studies
(15-keto-13,14-dihydroprostaglandin f2alpha)		Trials
(15-keto-13,14-dihydroprostaglandin f2alpha)		Recent Studies (post-2010) (15-keto-13,14-dihydroprostaglandin f2alpha)
460306784650

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hunter, M; Lamming, GE; Mann, GE; Pettibone, DJ; Scholey, D1

Other Studies

1 other study(ies) available for l 368899 and 15-keto-13,14-dihydroprostaglandin f2alpha

ArticleYear
Attenuation of PGF2alpha release in ewes infused with the oxytocin antagonist L-368,899.
    Domestic animal endocrinology, 2003, Volume: 25, Issue:3

    Topics: Animals; Camphanes; Corpus Luteum; Dinoprost; Dose-Response Relationship, Drug; Estrous Cycle; Female; Luteolysis; Oxytocin; Piperazines; Progesterone; Radioimmunoassay; Sheep; Uterus

2003